KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novavax (NVAX) Asset Writedowns and Impairment (2018 - 2025)

Novavax has reported Asset Writedowns and Impairment over the past 7 years, most recently at $94.5 million for Q4 2025.

  • Quarterly results put Asset Writedowns and Impairment at $94.5 million for Q4 2025, up 3735.28% from a year ago — trailing twelve months through Dec 2025 was $191.8 million (up 4541.84% YoY), and the annual figure for FY2025 was $97.8 million, up 2267.98%.
  • Asset Writedowns and Impairment for Q4 2025 was $94.5 million at Novavax, down from $97.0 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for NVAX hit a ceiling of $155.7 million in Q2 2022 and a floor of -$10.1 million in Q4 2023.
  • Median Asset Writedowns and Impairment over the past 4 years was $6.3 million (2023), compared with a mean of $44.0 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: crashed 93.51% in 2023 and later skyrocketed 3735.28% in 2025.
  • Novavax's Asset Writedowns and Impairment stood at $155.7 million in 2022, then tumbled by 106.47% to -$10.1 million in 2023, then skyrocketed by 124.43% to $2.5 million in 2024, then skyrocketed by 3735.28% to $94.5 million in 2025.
  • The last three reported values for Asset Writedowns and Impairment were $94.5 million (Q4 2025), $97.0 million (Q3 2025), and $300000.0 (Q2 2025) per Business Quant data.